Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    15781736 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed BNP for Cardio-Renal Decompensation Syndrome (BNP-CARDS)
Conditions: Congestive Heart Failure Exacerbation;   Renal Insufficiency
Intervention: Drug: Natrecor, a recombinant form of B-type Natriuretic Peptide, made by Scios, Inc. vs. placebo

Indicates status has not been verified in more than two years